Le Lézard
Classified in: Health
Subjects: PSF, CFG, MAT

Public Advisory - Health Canada warns about multiple unauthorized sexual enhancement products that may pose serious health risks


OTTAWA, ON, April 8, 2024 /CNW/ - Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts:

Health Canada maintains lists of unauthorized health products that may pose serious health risks so that the public can easily identify those they may have purchased and take appropriate action. You are encouraged to check back regularly for updates.

Product

Hazard Identified

Company

Action Taken

Unauthorized health products for sexual enhancement

Black Bull Extreme

Product tested by Health
Canada and found to contain
sildenafil and tadalafil

Neighbourhood Convenience

894 Mount Pleasant Rd,

Toronto, ON

Seized from retail
location

Black Mamba Premium
Triple Maximum

Product tested by Health
Canada and found to contain
sildenafil and tadalafil

Neighbourhood Convenience

894 Mount Pleasant Rd,

Toronto, ON

Seized from retail
location

Black Panther #1

Labelled to contain yohimbe

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

Rhino 7 Platinum 5000

Product with similar packaging
(previously seized) was tested
and found to contain sildenafil
and yohimbine

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

White Panther

Labelled to contain yohimbe

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

Wonderful Honey

Product tested by Health
Canada and found to contain
sildenafil

Chez Olivia Inc.

5130 Rue Beaubien Est

Montréal, QC

Seized from retail
location

Wonderfull Honey

Product tested by Health
Canada and found to contain
sildenafil

Chez Olivia Inc.

5130 Rue Beaubien Est

Montréal, QC

Seized from retail
location

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 08:20
Parse Biosciences Launches Single Cell Immune Profiling Products
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercodetm BCR and the expansion of its existing Evercodetm TCR product line. The new BCR solution and updates to...

at 08:20
Thermo Fisher Scientific Launches New CXCL10 Testing Service
For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complications. Now, a simple, urine-based assay that detects...

at 08:17
Invitation to presentation of RaySearch's interim report for the first quarter of 2024
Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2024 on May 17, 2024, at 10.00 am CEST. The report will be published on May 17, 2024, at 07.45 am and will be available together...

at 08:17
Wounded Warrior Project Shares Suicide Prevention Strategies at AAS24 Conference
One of the largest veterans nonprofits shares suicide risk reduction strategies at one of the leading conferences on suicide prevention this week. Wounded Warrior Project® (WWP) will offer insights applicable to veterans and others at risk....

at 08:15
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has set the record date for the...

at 08:15
New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged
Reprieve Cardiovascular, Inc. (?Reprieve'), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart...

More news about Health...


News published on and distributed by: